172@29@17@247!~!172@29@0@53!~!|news|podcast|setting-sail-podcast-heres-how-the-online-medical-platform-1mg-has-accelerated-covid-19-testing-in-delhi-ncr-5639611.html!~!news|moneycontrol|com!~!|controller|infinite_scroll_article.php!~!is_mobile=false
Moneycontrol
Subscribe to PRO at just Rs.33 per month. Use code SUPERPRO
you are here: HomeNewsPodcast
Last Updated : Aug 18, 2020 05:54 PM IST | Source: Moneycontrol.com

Setting Sail podcast | Here's how the online medical platform 1mg has accelerated COVID-19 testing in Delhi-NCR

Gaurav Agarwal talks about changes that 1mg went through during the COVID-19 times.

Technology has played a major role in testing and treating COVID-19 patients, preventing any contact between patients and doctors.

1mg has been one such platform and has contributed to the acceleration of coronavirus testing in the Delhi-NCR region.

Close

In this episode of Setting Sail, Moneycontrol's Priyanka Sahay talks to Gaurav Agarwal, co-founder of 1mg to find out more about the changes that the business went through during the COVID-19 times.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show
Tune in to the Setting Sail podcast for more.
First Published on Aug 3, 2020 05:41 pm
Sections